Ifp Advisors, Inc Nu Cana PLC Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.95 - $2.85 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$2.7 - $5.04 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$4.38 - $7.0 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$4.4 - $5.59 $4,400 - $5,590	-1,000 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$4.02 - $9.05 $4,019 - $9,050	1,000 New	1,000 $6,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $59M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.